Table 3 Symptomatic COVID-19 serum samples from outpatients, inpatients, and patients in intensive care units.

From: Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients

 

Outpatient (Outpt)

Inpatient (Inpt)

Intensive Care Unit (ICU)

Total number of serum samples

46

27

23

Sex (male:female:Unk)

15:25:6

14:9:4

12:11:0

Mean age, years (SD)

43.3 (13.6)

51.9 (17.7)

59.4 (15.0)

Race(W:B:A:Unk)

34:4:0:2

13:7:0:0

9:14:0:0

Hispanic or Latino

2

2

0

Died

0

0

3

Mean time from symptoms to admission (day)

n/a

11.4

5.9

Ventilatory support

0

0

15

ARDS severity (range)

n/a

n/a

24–146

  1. ARDS severity defined as PaO2/FiO2 (only reported in 5 subjects). White (W), Caucasian/European; Black (B), African American/African; Asian (A); Unk (unknown); SD standard deviation, n/a not available, ARDS acute respiratory distress syndrome, PaO2 oxygen in arterial blood, FiO2 oxygen in the inspired air.
Back to article page